These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33144218)

  • 1. Defining the clinical genomic landscape for real-world precision oncology.
    Beer PA; Cooke SL; Chang DK; Biankin AV
    Genomics; 2020 Nov; 112(6):5324-5330. PubMed ID: 33144218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.
    Doig KD; Love CG; Conway T; Seleznev A; Ma D; Fellowes A; Blombery P; Fox SB
    BMC Med Genomics; 2022 Mar; 15(1):70. PubMed ID: 35346197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A user guide for the online exploration and visualization of PCAWG data.
    Goldman MJ; Zhang J; Fonseca NA; Cortés-Ciriano I; Xiang Q; Craft B; Piñeiro-Yáñez E; O'Connor BD; Bazant W; Barrera E; Muñoz-Pomer A; Petryszak R; Füllgrabe A; Al-Shahrour F; Keays M; Haussler D; Weinstein JN; Huber W; Valencia A; Park PJ; Papatheodorou I; Zhu J; Ferretti V; Vazquez M
    Nat Commun; 2020 Jul; 11(1):3400. PubMed ID: 32636365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
    Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
    Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision diagnostics in cancer: Predict, prevent, and personalize.
    Crabtree JS; Miele L
    Prog Mol Biol Transl Sci; 2022; 190(1):39-56. PubMed ID: 36008001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications.
    Imperial R; Toor OM; Hussain A; Subramanian J; Masood A
    Semin Cancer Biol; 2019 Feb; 54():14-28. PubMed ID: 29175106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis.
    Hartmaier RJ; Albacker LA; Chmielecki J; Bailey M; He J; Goldberg ME; Ramkissoon S; Suh J; Elvin JA; Chiacchia S; Frampton GM; Ross JS; Miller V; Stephens PJ; Lipson D
    Cancer Res; 2017 May; 77(9):2464-2475. PubMed ID: 28235761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolutionary history of 2,658 cancers.
    Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P;
    Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Whole-Genome Sequencing: The Quest for Comprehensive Genomic Profiling in Routine Oncology Care.
    Nelson AC; Yohe SL
    J Mol Diagn; 2021 Jul; 23(7):784-787. PubMed ID: 34020043
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer Genomics.
    Fonseca-Montaño MA; Blancas S; Herrera-Montalvo LA; Hidalgo-Miranda A
    Arch Med Res; 2022 Dec; 53(8):723-731. PubMed ID: 36460546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
    Rasnic R; Brandes N; Zuk O; Linial M
    BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome.
    Rusch M; Nakitandwe J; Shurtleff S; Newman S; Zhang Z; Edmonson MN; Parker M; Jiao Y; Ma X; Liu Y; Gu J; Walsh MF; Becksfort J; Thrasher A; Li Y; McMurry J; Hedlund E; Patel A; Easton J; Yergeau D; Vadodaria B; Tatevossian RG; Raimondi S; Hedges D; Chen X; Hagiwara K; McGee R; Robinson GW; Klco JM; Gruber TA; Ellison DW; Downing JR; Zhang J
    Nat Commun; 2018 Sep; 9(1):3962. PubMed ID: 30262806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
    Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
    Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating cancer genomes sequencing revolution into surgical oncology practice.
    Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
    J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
    Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
    Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-cancer whole-genome analyses of metastatic solid tumours.
    Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
    Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.